Variant report

Variant	nsv583160
Chromosome Location	chr2:133672718-133674029
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:3)
CpG islands
(count:61)
Chromatin interactive
region (count:0)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:3 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	EBF1	chr2:133673346-133673757	GM12878	blood:	n/a	chr2:133673624-133673637 chr2:133673624-133673635 chr2:133673626-133673636 chr2:133673626-133673635
2	POLR2A	chr2:133673732-133674203	H1-neurons	neurons:	n/a	n/a
3	POLR2A	chr2:133673706-133674218	H1-neurons	neurons:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:133672682-133672732	NHBE	bronchial:	n/a
2	chr2:133672682-133672732	GM12878	blood:	n/a
3	chr2:133672682-133672732	MCF10A-Er-Src	breast:	n/a
4	chr2:133672682-133672732	PrEC	prostate:	n/a
5	chr2:133672682-133672732	NHDF-neo	bronchial:	n/a
6	chr2:133672682-133672732	HRCEpiC	kidney:	n/a
7	chr2:133672682-133672732	ProgFib	skin:	n/a
8	chr2:133672682-133672732	Jurkat	blood:	n/a
9	chr2:133672682-133672732	HCM	heart:	n/a
10	chr2:133672682-133672732	ECC-1	luminal epithelium:	n/a
11	chr2:133672682-133672732	GM19239	blood:	n/a
12	chr2:133672682-133672732	GM12891	blood:	n/a
13	chr2:133672682-133672732	PFSK-1	brain:	n/a
14	chr2:133672682-133672732	HUVEC	blood vessel:	n/a
15	chr2:133672682-133672732	HIPEpiC	eye:	n/a
16	chr2:133672682-133672732	K562	blood:	n/a
17	chr2:133672682-133672732	A549	lung:	n/a
18	chr2:133672682-133672732	MCF-7	breast:	n/a
19	chr2:133672682-133672732	GM12892	blood:	n/a
20	chr2:133672682-133672732	SAEC	small airway:	n/a
21	chr2:133672682-133672732	T-47D	breast:	n/a
22	chr2:133672682-133672732	U87	brain:	n/a
23	chr2:133672682-133672732	HEK293	kidney:	embryo
24	chr2:133672682-133672732	GM06990	blood:	n/a
25	chr2:133672682-133672732	SK-N-MC	brain:	n/a
26	chr2:133672682-133672732	HCPEpiC	choroid plexus:	n/a
27	chr2:133672682-133672732	SK-N-SH	brain:	n/a
28	chr2:133672682-133672732	HRE	kidney:	n/a
29	chr2:133672682-133672732	H1-hESC	embryonic stem cell:	embryo
30	chr2:133672682-133672732	CMK	blood:	n/a
31	chr2:133672682-133672732	NT2-D1	testis:	n/a
32	chr2:133672682-133672732	HepG2	liver:	n/a
33	chr2:133672682-133672732	HCF	heart:	n/a
34	chr2:133672682-133672732	HPAEpiC	pulmonary alveolar:	n/a
35	chr2:133672682-133672732	AG09309	skin:	n/a
36	chr2:133672682-133672732	Caco-2	colon:	n/a
37	chr2:133672682-133672732	PANC-1	pancreas:	n/a
38	chr2:133672682-133672732	AG09319	gingival:	n/a
39	chr2:133672682-133672732	RPTEC	kidney:	n/a
40	chr2:133672682-133672732	Hela-S3	cervix:	n/a
41	chr2:133672682-133672732	SKMC	muscle:	n/a
42	chr2:133672682-133672732	IMR90	lung:	fetal
43	chr2:133672682-133672732	NB4	blood:	n/a
44	chr2:133672682-133672732	AG10803	skin:	n/a
45	chr2:133672682-133672732	NH-A	brain:	n/a
46	chr2:133672682-133672732	AG04450	lung:	fetal
47	chr2:133672682-133672732	HMEC	breast:	n/a
48	chr2:133672682-133672732	HEEpiC	esophagus:	n/a
49	chr2:133672682-133672732	BE2_C	brain:	n/a
50	chr2:133672682-133672732	LNCaP	prostate:	n/a

No data

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GPR39-3	chr2:133673130-133673224	ENSG00000233729.1

No data

Variant related genes	Relation type
ENSG00000228721	TF binding region
ENSG00000233729	TF binding region
ENSG00000228721	CpG island
ENSG00000233729	CpG island

Extended variants
information (count: 49 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:49 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs13409893	chr2:133672718-133672719	Weak transcription Genic enhancers Enhancers	CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs35158313	chr2:133672763-133672764	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs544488092	chr2:133672780-133672781	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs139184475	chr2:133672784-133672785	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs573489636	chr2:133672792-133672793	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs540891958	chr2:133672802-133672803	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs571191595	chr2:133672805-133672806	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs184169026	chr2:133672817-133672818	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs57820130	chr2:133672832-133672833	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs4953863	chr2:133672853-133672854	Weak transcription Genic enhancers Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs544218698	chr2:133672860-133672861	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs533687275	chr2:133672862-133672863	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs77245711	chr2:133672877-133672878	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs533027113	chr2:133672934-133672935	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs149931821	chr2:133672941-133672942	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs560259455	chr2:133672944-133672945	Weak transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs34754965	chr2:133673105-133673106	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs372779437	chr2:133673162-133673163	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
19	rs79402061	chr2:133673240-133673241	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs568124761	chr2:133673242-133673243	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs188830210	chr2:133673255-133673256	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs146474734	chr2:133673266-133673267	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs35046289	chr2:133673319-133673320	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs192607318	chr2:133673344-133673345	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs539904052	chr2:133673348-133673349	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs558081480	chr2:133673366-133673367	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs371817377	chr2:133673378-133673379	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs182576478	chr2:133673381-133673382	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs571086609	chr2:133673423-133673424	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs77654384	chr2:133673448-133673449	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs376360743	chr2:133673451-133673452	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs187002236	chr2:133673473-133673474	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs544255831	chr2:133673517-133673518	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs76736281	chr2:133673525-133673526	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs191914721	chr2:133673548-133673549	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs545060710	chr2:133673558-133673559	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs560094193	chr2:133673560-133673561	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs143266854	chr2:133673573-133673574	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs13401736	chr2:133673609-133673610	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs560894568	chr2:133673652-133673653	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs146674150	chr2:133673705-133673706	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs116578835	chr2:133673760-133673761	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs184519188	chr2:133673763-133673764	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs538567968	chr2:133673873-133673874	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs546766420	chr2:133673874-133673875	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs551803338	chr2:133673918-133673919	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs189177106	chr2:133673937-133673938	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs534443452	chr2:133673995-133673996	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs79944228	chr2:133674029-133674030	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:58)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Developmental delay	21147756	CNVD
Mental retardation	17621639	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	21399695	CNVD
Breast cancer	21509527	CNVD
Mental retardation	17124404	CNVD
Colorectal cancer	20459617	CNVD
Neuroticism	17667963	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	22522925	CNVD
Oral cancer	21386901	CNVD

Chromatin state (count:24 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:133667200-133681600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr2:133667600-133673000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
3	chr2:133668800-133676400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr2:133669800-133672800	Weak transcription	Fetal Lung	lung
5	chr2:133669800-133672800	Weak transcription	Fetal Muscle Trunk	muscle
6	chr2:133670200-133672800	Weak transcription	Fetal Muscle Leg	muscle
7	chr2:133670400-133673400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr2:133672200-133673600	Enhancers	Fetal Heart	heart
9	chr2:133672600-133673000	Genic enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
10	chr2:133672600-133674200	Enhancers	Adipose Nuclei	Adipose
11	chr2:133672800-133673000	Enhancers	Lung	lung
12	chr2:133672800-133673200	Enhancers	Fetal Muscle Trunk	muscle
13	chr2:133672800-133673400	Enhancers	Fetal Muscle Leg	muscle
14	chr2:133672800-133673400	Enhancers	Right Atrium	heart
15	chr2:133672800-133674000	Enhancers	Fetal Lung	lung
16	chr2:133672800-133674000	Enhancers	Right Ventricle	heart
17	chr2:133672800-133674400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr2:133673000-133674200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr2:133673000-133681000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
20	chr2:133673200-133674000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
21	chr2:133673400-133674000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
22	chr2:133673600-133688800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
23	chr2:133673800-133674000	Enhancers	Lung	lung
24	chr2:133674000-133676400	Weak transcription	Fetal Lung	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links